ArticleExperimental and therapeutic medicine2018
Drug-induced Rowell syndrome, a rare and difficult to manage disease: A case report.
Article in Experimental and therapeutic medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 20 citations in OpenAlex.
- Systemic lupus erythematosus presenting as atypical erythema multiforme-like lesions: a diagnostic challenge.BMC oral health · 2025Article
- Pathology and Treatment of Psoriasis Using Nanoformulations.Biomedicines · 2023Review
- Mucocutaneous lesions associated with SARS-CoV-2 infection (Review).Experimental and therapeutic medicine · 2022Review
- Diagnostic methods for the etiological assessment of infectious corneal pathology (Review).Experimental and therapeutic medicine · 2022Review
- Utilization of Rituximab for Refractory Rowell Syndrome.Case reports in rheumatology · 2021Article
- Influence of phytochemicals in induced psoriasis (Review).Experimental and therapeutic medicine · 2020Review
- Rowell's syndrome: a rare but distinct entity in rheumatology.BMJ case reports · 2020Article
- Rowell Syndrome: A Diagnostic Challenge.The Journal of clinical and aesthetic dermatology · 2020Article
- A Case of Rhupus with Rowell Syndrome.Open access rheumatology : research and reviews · 2020Article
- A Week of Oral Terbinafine Pulse Regimen Every Three Months to Treat all Dermatophyte Onychomycosis.Journal of fungi (Basel, Switzerland) · 2019Article
- Cutaneous leukocytoclastic vasculitis associated with erlotinib treatment: A case report and review of the literature.Experimental and therapeutic medicine · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rowell syndrome is defined as the association between lupus erythematosus, erythema multiforme-like lesions and characteristic immunological changes including positive tests for rheumatoid factor, speckled antinuclear antibody, positive anti-Ro or anti-La antibodies. The present report presents the case of a 45-year-old female patient who was previously diagnosed in January 2010 with terbinafine-induced subacute cutaneous lupus erythematosus and was admitted for a skin eruption consisting of erythematous-papular erythema multiforme-like lesions, primarily on the trunk and limbs. The associated symptoms consisted of fatigability, myalgia and gonalgia. In October 2015, the illness reoccurred ~1 week after the initiation of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.